4/2
08:31 am
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Maxim Group. They set a "buy" rating and a $17.00 price target on the stock.
Medium
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Maxim Group. They set a "buy" rating and a $17.00 price target on the stock.
3/26
08:00 am
nvct
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
Medium
Report
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
3/17
08:11 am
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $19.00 price target on the stock.
Medium
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $19.00 price target on the stock.
3/14
08:00 am
nvct
Nuvectis Pharma to Participate in the 37th Annual Roth Conference
Low
Report
Nuvectis Pharma to Participate in the 37th Annual Roth Conference
3/5
08:44 am
nvct
Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation
Low
Report
Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation
3/4
08:00 am
nvct
Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC
Medium
Report
Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC
2/27
11:25 am
nvct
Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets [Yahoo! Finance]
Low
Report
Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets [Yahoo! Finance]
2/27
10:43 am
nvct
Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets
Low
Report
Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets
2/25
12:08 pm
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) had its price target lowered by analysts at HC Wainwright from $21.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) had its price target lowered by analysts at HC Wainwright from $21.00 to $11.00. They now have a "buy" rating on the stock.
2/25
09:34 am
nvct
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights [Yahoo! Finance]
Medium
Report
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights [Yahoo! Finance]
2/25
08:00 am
nvct
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights
Medium
Report
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights
2/7
08:30 am
nvct
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
Medium
Report
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
2/5
10:10 am
nvct
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock [Yahoo! Finance]
Low
Report
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock [Yahoo! Finance]
2/5
09:01 am
nvct
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
High
Report
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
2/5
04:04 am
nvct
Nuvectis Pharma Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
High
Report
Nuvectis Pharma Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
2/4
04:05 pm
nvct
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
High
Report
Nuvectis Pharma Announces Proposed Public Offering of Common Stock